IBEX Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
IBEX Wealth Advisors's LLY Position: Q1 2026 in Review
IBEX Wealth Advisors increased its Eli Lilly (LLY) stake by 13% in Q1 2026, buying an estimated $939K and bringing the position to 8,093 shares worth $7.44M. The position accounts for 0.69% of the portfolio, ranked #49.
IBEX Wealth Advisors first reported a position in LLY in Q1 2019 and has held it in 17 quarters since. The position peaked at $10.7M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- IBEX Wealth Advisors held 8,093 shares of Eli Lilly worth $7.44M as of Q1 2026.
- IBEX Wealth Advisors bought 926 Eli Lilly shares in Q1 2026, an estimated $939K.
- Eli Lilly made up 0.69% of IBEX Wealth Advisors's portfolio in Q1 2026, its #49 holding.
- IBEX Wealth Advisors first reported a position in Eli Lilly in Q1 2019 and has held it in 17 quarters since.
- IBEX Wealth Advisors's Eli Lilly position peaked at $10.7M in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on IBEX Wealth Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.